Browsing by Author Delgado, V

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
DECREASE IN AMMONIUM LEVELS AND INCREASE IN THE NEUTROPHILS PHAGOCYTIC CAPACITY IN CIRRHOTIC PATIENTS AFTER THE INGESTION OF AGAVE INULIN AND A PROBIOTIC MIXTURE OF BIFIDOBACTERIAS AND LACTOBILLUSSegura-Ortega, JE; Moreno-Luna, LE; Delgado, V; Zuniga-Partida, V; Fafutis-Morris, M--
DECREASE IN AMMONIUM LEVELS AND INCREASE IN THE NEUTROPHILS PHAGOCYTIC CAPACITY IN CIRRHOTIC PATIENTS AFTER THE INGESTION OF AGAVE INULIN AND A PROBIOTIC MIXTURE OF BIFIDOBACTERIAS AND LACTOBILLUSSegura-Ortega, JE; Moreno-Luna, LE; Delgado, V; Zuniga-Partida, V; Fafutis-Morris, M--
Polymorphism of-413 T/A of the Hemeoxygenase-1 gen as a Factor for the Development of Portal Hypertension in patients with CirrhosisSegura-Ortega, JE; Delgado, V; Moreno-Luna, LE; Fafutis-Morris, M--
Polymorphism of-413 T/A of the Hemeoxygenase-1 gen as a Factor for the Development of Portal Hypertension in patients with CirrhosisSegura-Ortega, JE; Delgado, V; Moreno-Luna, LE; Fafutis-Morris, M--
PORTAL HYPERTENSION IN LIVER CIRRHOSIS: DINUCLEOTIDE(GT)N POLYMORPHISM OF HMOX1 AND THE INFLAMMATORY PROFILESegura-Ortega, JE; Guerrero-Cruz, S; Guillen-Vargas, C; Moreno-Luna, LE; Delgado, V; Fafutis-Morris, M--
PORTAL HYPERTENSION IN LIVER CIRRHOSIS: DINUCLEOTIDE(GT)N POLYMORPHISM OF HMOX1 AND THE INFLAMMATORY PROFILESegura-Ortega, JE; Guerrero-Cruz, S; Guillen-Vargas, C; Moreno-Luna, LE; Delgado, V; Fafutis-Morris, M--
PREBIOTIC VS SYMBIOTIC TO DECREASE AMMONIUM LEVELS IN CIRRHOTIC PATIENTS WITH AND WITHOUT MINIMAL HEPATIC ENCEPHALOPATHYLuna, LEM; Fafutis-Morris, M; Segura-Ortega, JE; Delgado, V; Zuniga-Partida, V--
PREBIOTIC VS SYMBIOTIC TO DECREASE AMMONIUM LEVELS IN CIRRHOTIC PATIENTS WITH AND WITHOUT MINIMAL HEPATIC ENCEPHALOPATHYLuna, LEM; Fafutis-Morris, M; Segura-Ortega, JE; Delgado, V; Zuniga-Partida, V--
Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by activation of metalloproteinases and down-regulation of collagens gene expression.Armendariz-Borunda, J; Bueno, M; Salgado, S; Delgado, V; Aguilar-Cordova, E--
Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by activation of metalloproteinases and down-regulation of collagens gene expression.Armendariz-Borunda, J; Bueno, M; Salgado, S; Delgado, V; Aguilar-Cordova, E--